KR100699396B1 - 자기 공명 연구 방법 - Google Patents

자기 공명 연구 방법 Download PDF

Info

Publication number
KR100699396B1
KR100699396B1 KR1020007007423A KR20007007423A KR100699396B1 KR 100699396 B1 KR100699396 B1 KR 100699396B1 KR 1020007007423 A KR1020007007423 A KR 1020007007423A KR 20007007423 A KR20007007423 A KR 20007007423A KR 100699396 B1 KR100699396 B1 KR 100699396B1
Authority
KR
South Korea
Prior art keywords
delete delete
formulation
agent
magnetic field
polarization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020007007423A
Other languages
English (en)
Korean (ko)
Other versions
KR20010040318A (ko
Inventor
잔 헨릭 아르덴크쟤르-라센
오스카 악셀슨
클래스 골만
라르스-고란 위스트랜드
죠르주 한슨
이브 레은바흐
스테판 피터슨
Original Assignee
지이 헬스케어 에이에스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9800158.9A external-priority patent/GB9800158D0/en
Priority claimed from GBGB9813795.3A external-priority patent/GB9813795D0/en
Application filed by 지이 헬스케어 에이에스 filed Critical 지이 헬스케어 에이에스
Publication of KR20010040318A publication Critical patent/KR20010040318A/ko
Application granted granted Critical
Publication of KR100699396B1 publication Critical patent/KR100699396B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A61K49/1815—Suspensions, emulsions, colloids, dispersions compo-inhalant, e.g. breath tests
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/28—Details of apparatus provided for in groups G01R33/44 - G01R33/64
    • G01R33/282—Means specially adapted for hyperpolarisation or for hyperpolarised contrast agents, e.g. for the generation of hyperpolarised gases using optical pumping cells, for storing hyperpolarised contrast agents or for the determination of the polarisation of a hyperpolarised contrast agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/62—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using double resonance

Landscapes

  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Signal Processing (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • General Induction Heating (AREA)
  • Magnetic Ceramics (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
KR1020007007423A 1998-01-05 1998-12-23 자기 공명 연구 방법 Expired - Fee Related KR100699396B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9800158.9A GB9800158D0 (en) 1998-01-05 1998-01-05 Method
GB9800158.9 1998-01-05
GBGB9813795.3A GB9813795D0 (en) 1998-06-25 1998-06-25 Method
GB9813795.3 1998-06-25

Publications (2)

Publication Number Publication Date
KR20010040318A KR20010040318A (ko) 2001-05-15
KR100699396B1 true KR100699396B1 (ko) 2007-03-27

Family

ID=26312888

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020007007423A Expired - Fee Related KR100699396B1 (ko) 1998-01-05 1998-12-23 자기 공명 연구 방법

Country Status (15)

Country Link
US (2) US6278893B1 (https=)
EP (2) EP2119457B1 (https=)
JP (1) JP4764548B2 (https=)
KR (1) KR100699396B1 (https=)
CN (2) CN1138154C (https=)
AU (1) AU752308C (https=)
BR (1) BRPI9813244B1 (https=)
CA (1) CA2317526C (https=)
ES (1) ES2393833T3 (https=)
HU (1) HU229718B1 (https=)
IL (1) IL136780A0 (https=)
NO (1) NO334035B1 (https=)
NZ (1) NZ505151A (https=)
RU (1) RU2221255C2 (https=)
WO (1) WO1999035508A1 (https=)

Families Citing this family (150)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI982069A7 (fi) * 1996-03-29 1998-11-10 Lawrence Berkeley Nat Laboratory NMR:n ja MRI:n tehostaminen hyperpolaroitujen jalokaasujen läsnä olles sa
US8765099B2 (en) * 1996-04-08 2014-07-01 Koninklijke Philips N.V. Magnetic resonance imaging hyperpolarization of liquids or solids by light with orbital angular momentum
WO2009081360A1 (en) * 2007-12-20 2009-07-02 Koninklijke Philips Electronics N.V. Magnetic resonance imaging using hyperpolarization of liquids or solids by light with orbital angular momentum
EP0951650B1 (en) * 1997-01-08 2003-12-10 Amersham Health AS Method of magnetic resonance imaging
US6278893B1 (en) * 1998-01-05 2001-08-21 Nycomed Imaging As Method of magnetic resonance imaging of a sample with ex vivo polarization of an MR imaging agent
BR9911346A (pt) * 1998-06-17 2001-03-13 Medi Physics Inc Dispositivo de transporte de gás hiperpolarizado e método de transporte associado
US6237363B1 (en) * 1998-09-30 2001-05-29 Medi-Physics, Inc. Hyperpolarized noble gas extraction methods masking methods and associated transport containers
US6284222B1 (en) 1998-11-03 2001-09-04 Medi--Physics, Inc. Hyperpolarized helium-3 microbubble gas entrapment methods
US7501236B1 (en) * 1998-12-30 2009-03-10 Ge Healthcare Limited NMR spectroscopic in vitro assay using hyperpolarization
EP1155339A1 (en) 1999-02-23 2001-11-21 Medi-Physics, Inc. Portable system for monitoring the polarization level of a hyperpolarized gas during transport
US6574496B1 (en) * 1999-05-19 2003-06-03 Amersham Health As Magnetic resonance imaging
US20020058869A1 (en) * 1999-05-19 2002-05-16 Oskar Axelsson Methods of magnetic resonance imaging (MRI) using contract agent solutions formed from the dissolution of hyperpolarised materials
US6295834B1 (en) 1999-06-30 2001-10-02 Medi-Physics, Inc. NMR polarization monitoring coils, hyperpolarizers with same, and methods for determining the polarization level of accumulated hyperpolarized noble gases during production
DE10009166A1 (de) * 2000-02-26 2001-08-30 Philips Corp Intellectual Pty Verfahren zur Lokalisierung von Objekten in der interventionellen Radiologie
US6630126B2 (en) 2000-03-13 2003-10-07 Medi-Physics, Inc. Diagnostic procedures using direct injection of gaseous hyperpolarized 129Xe and associated systems and products
GB0009353D0 (en) * 2000-04-14 2000-05-31 Nycomed Imaging As Method
GB0014463D0 (en) * 2000-06-14 2000-08-09 Nycomed Amersham Plc NMR Method
CA2414610A1 (en) * 2000-07-13 2002-01-24 Medi-Physics, Inc. Diagnostic procedures using 129xe spectroscopy characteristic chemical shift to detect pathology in vivo
GB0022341D0 (en) * 2000-09-12 2000-10-25 Nycomed Imaging As Method
NO20004561D0 (no) * 2000-09-13 2000-09-13 Nycomed Imaging As Metode for magnetisk resonansavbildning
BR0115124B1 (pt) * 2000-11-03 2012-12-25 dispositivo para fundir uma amostra hiperpolarizada sàlida, mÉtodo para produzir uma amostra hiperpolarizada fundida, e, uso de um dispositivo ou mÉtodo.
JP4061192B2 (ja) 2000-11-03 2008-03-12 ジーイー・ヘルスケア・アクスイェ・セルスカプ 分極ｎｍｒ試料用のデバイス及び方法
US7126332B2 (en) * 2001-07-20 2006-10-24 Baker Hughes Incorporated Downhole high resolution NMR spectroscopy with polarization enhancement
GB0122049D0 (en) * 2001-09-12 2001-10-31 Nycomed Imaging As Method
RU2281527C2 (ru) * 2001-11-02 2006-08-10 Амершем Хелт АС Способ и устройство для плавления поляризованных ямр-образцов
NO20023357D0 (no) * 2002-04-19 2002-07-11 Amersham Health As Blanding
GB0219954D0 (en) * 2002-08-29 2002-10-02 Amersham Health R & D Ab Method and apparatus for producing contrast agents for magnetic resonance imaging
NO20025124D0 (no) 2002-10-25 2002-10-25 Amersham Health As Metode
NO20025711D0 (no) * 2002-11-27 2002-11-27 Amersham Health As Magnetisk resonansmetode
US20060173283A1 (en) * 2002-11-27 2006-08-03 Oskar Axelsson Method of magnetic resonance imaging
NO20025738D0 (no) * 2002-11-29 2002-11-29 Amersham Health As Metode
DE10259793B4 (de) * 2002-12-19 2009-10-15 Siemens Ag Verfahren zur Bildgebung eines Stoffwechselvorgangs eines Lebewesens
DE10335663A1 (de) * 2003-08-04 2005-03-10 Siemens Ag Verfahren zur automatischen Kalibrierung von Perfusionsparameterbildern
ES2545377T3 (es) * 2004-07-30 2015-09-10 Ge Healthcare As Radicales y su uso como agentes paramagnéticos en un proceso de polarización nuclear dinámica
WO2006011810A2 (en) * 2004-07-30 2006-02-02 Ge Healthcare As Mr imaging method for the discrimination between healthy and tumour tissue
NZ552898A (en) * 2004-07-30 2011-02-25 Ge Healthcare As Method of producing a composition, composition and its use
NO338547B1 (no) * 2004-07-30 2016-09-05 Ge Healthcare As Fremgangsmåte for fremstilling av en flytende sammensetning omfattende hyperpolarisert 13C-pyruvat, sammensetningen og anvendelse av den for fremstilling av hyperpolarisert 13C-pyruvat
WO2006054903A2 (en) * 2004-11-19 2006-05-26 Ge Healthcare As Method of cardiac imaging with the use of hyperpolarized 13 c-pyruvate
US7276905B2 (en) * 2005-07-11 2007-10-02 General Electric Company Method and system of tracking an intracorporeal device with MR imaging
JP2007021008A (ja) * 2005-07-20 2007-02-01 Hitachi Ltd Ｄｎｐ過分極手段を備えた磁気共鳴イメージング装置
US20070025918A1 (en) * 2005-07-28 2007-02-01 General Electric Company Magnetic resonance imaging (MRI) agents: water soluble carbon-13 enriched fullerene and carbon nanotubes for use with dynamic nuclear polarization
WO2007035871A1 (en) * 2005-09-21 2007-03-29 Massachusetts Institute Of Technology Systems and methods for tuning properties of nanoparticles
WO2007038626A2 (en) * 2005-09-28 2007-04-05 President And Fellows Of Harvard College Hyperpolarized solid materials with long spin relaxation times for use as imaging agents in magnetic resonance imaging
WO2007044867A2 (en) * 2005-10-11 2007-04-19 Huntington Medical Research Institutes Imaging agents and methods of use thereof
US20080287774A1 (en) * 2005-11-06 2008-11-20 Rachel Katz-Brull Magnetic Resonance Imaging and Spectroscopy Means and Methods Thereof
JP5475995B2 (ja) * 2005-12-01 2014-04-16 ジーイー・ヘルスケア・アクスイェ・セルスカプ 動的核分極（ｄｎｐ）法
NO20055681D0 (no) * 2005-12-01 2005-12-01 Amersham Health As Method of dynamic nuclear polarisation
WO2007070466A2 (en) * 2005-12-10 2007-06-21 The President And Fellows Of Harvard College In situ hyperpolarization of imaging agents
PL1962912T3 (pl) * 2005-12-16 2013-03-29 Ge Healthcare As Sposób wytwarzania hiperpolaryzowanych karboksylanów amin organicznych
EP1984757A4 (en) * 2006-01-11 2009-11-04 Harvard College EX-VIVO HYPERPOLARIZATION OF ILLUSTRATORS
US8703102B2 (en) 2008-04-04 2014-04-22 Millikelvin Technologies Llc Systems and methods for producing hyperpolarized materials and mixtures thereof
WO2012129512A1 (en) * 2011-03-23 2012-09-27 Millikelvin Technologies Llc Improved techniques, systems and machine readable programs for magnetic resonance
AU2013205838B2 (en) * 2006-02-21 2016-03-17 Avrum Belzer Hyperpolarization Methods, Systems and Compositions
EP1986702A4 (en) 2006-02-21 2012-12-12 Avrum Belzer HYPERPOLARIZATION PROCEDURES, SYSTEMS AND COMPOSITIONS
US20100233096A1 (en) * 2006-03-29 2010-09-16 Lerche Mathilde H Method to produce hyperpolarised carboxylates and sulphonates
US7205764B1 (en) * 2006-04-11 2007-04-17 Varian, Inc. Method and apparatus for increasing the detection sensitivity in a high resolution NMR analysis
EP2015889B1 (en) * 2006-05-11 2014-07-09 Bell Helicopter Textron Inc. Device and method for repairing structural components
WO2007134160A2 (en) * 2006-05-12 2007-11-22 Massachusetts Institute Of Technology Temperature-jump dynamic nuclear polarization
EP2018545A4 (en) * 2006-05-12 2011-03-09 Massachusetts Inst Technology BIRDICAL POLARIZATION AGENTS FOR DYNAMIC NUCLEAR POLARIZATION APPLICATIONS
US8623327B2 (en) 2006-06-19 2014-01-07 Beth Israel Deaconess Medical Center, Inc. Imaging agents for use in magnetic resonance blood flow/perfusion imaging
CN101506679B (zh) * 2006-08-18 2013-03-06 通用电气医疗集团股份有限公司 细胞死亡的13c-mr成像或波谱分析
KR20140144312A (ko) 2006-08-30 2014-12-18 지이 헬스케어 에이에스 동적 핵 분극화 방법 및 이러한 방법에서 사용되는 화합물 및 조성물
CA3065182C (en) 2006-10-03 2022-05-17 Duke University Systems and methods for assessing pulmonary gas transfer using hyperpolarized 129xe mri
US7631507B2 (en) 2006-11-02 2009-12-15 General Electric Company Methods and devices for polarized samples for use in MRI
US8849372B2 (en) * 2006-11-22 2014-09-30 The General Hospital Corporation Method for magnetic resonance imaging using stimulus induced rotary saturation with a contrast agent
WO2008072142A1 (en) * 2006-12-11 2008-06-19 Koninklijke Philips Electronics N.V. Fibre tracking on the basis of macroscopic information
WO2008086534A1 (en) * 2007-01-11 2008-07-17 Huntington Medical Research Institutes Imaging agents and methods of use thereof
US20080240998A1 (en) 2007-03-28 2008-10-02 Urbahn John A Fluid path system for dissolution and transport of a hyperpolarized material
US7519492B2 (en) * 2007-05-02 2009-04-14 General Electric Company Apparatus and method for fully automated closed system quality control of a substance
US7610157B2 (en) * 2007-05-02 2009-10-27 General Electric Company Apparatus and method for fully automated closed system pH measurement
US20080275668A1 (en) * 2007-05-02 2008-11-06 General Electric Company Apparatus and method for fully automated closed system optical measurement of volume
US7741844B2 (en) 2007-05-07 2010-06-22 General Electric Company Method and system for magnetic resonance imaging using labeled contrast agents
US9042978B2 (en) * 2007-05-11 2015-05-26 Neurometrix, Inc. Method and apparatus for quantitative nerve localization
GB2450316A (en) * 2007-06-18 2008-12-24 Univ York Hyperpolarizing nuclei
DE102007028901B4 (de) * 2007-06-22 2010-07-22 Siemens Ag Verfahren und Vorrichtung zur automatischen Bestimmung von Perfusion mittels einer Magnetresonanzanlage
US20080314836A1 (en) * 2007-06-22 2008-12-25 General Electric Company Methods and devices for dynamic filtration of pharmaceutical products
US9227173B2 (en) 2007-06-22 2016-01-05 General Electric Company Methods for dynamic filtration of pharmaceutical products
GB0713074D0 (en) * 2007-07-05 2007-08-15 Univ London A method of hyperpolarising a magnetic resonance agent
PL2180902T3 (pl) * 2007-08-27 2012-07-31 Ge Healthcare Ltd Ośrodek obrazujący zawierający hiperpolaryzowany ¹³C-octan oraz jego zastosowanie
US20100233089A1 (en) * 2007-10-05 2010-09-16 Huntington Medical Research Institutes Imaging of genetic material with magnetic resonance
EP2072061A1 (en) 2007-12-19 2009-06-24 GE Healthcare Limited Composition and method for generating a metabolic profile using 13C-MR detection
JP4871311B2 (ja) * 2008-02-26 2012-02-08 株式会社日立製作所 核磁気共鳴装置、磁気共鳴イメージング装置および磁気共鳴分析装置
GB0804422D0 (en) * 2008-03-10 2008-04-16 Univ Southampton An agent for transporting nuclear spin order and for magnetic resonance imaging
US20140223923A1 (en) * 2008-04-04 2014-08-14 Millikelvin Technologies Llc Systems and methods for producing hyperpolarized materials and mixtures thereof
WO2009129265A1 (en) * 2008-04-14 2009-10-22 Huntington Medical Research Institutes Methods and apparatus for pasadena hyperpolarization
US8763410B2 (en) 2008-04-21 2014-07-01 General Electric Company Method and apparatus for the dissolution and filtration of a hyperpolarized agent with a neutral dissolution media
US20110038802A1 (en) 2008-05-02 2011-02-17 Zhong-Min Hu Method of determining alanine transaminase (alt) activity by 13c-mr detection using hyperpolarised 13c-pyruvate
US9658300B1 (en) * 2008-08-19 2017-05-23 California Institute Of Technology Method and apparatus for preparation of spin polarized reagents
US9289518B2 (en) * 2008-08-22 2016-03-22 The Brigham And Women's Hospital Enhanced 13C NMR by thermal mixing with hyperpolarized 129XE
US7633290B1 (en) 2008-09-09 2009-12-15 General Electric Company Apparatus and method for a fully automated preparation of a hyperpolarizing imaging agent
US20100092390A1 (en) * 2008-10-09 2010-04-15 President And Fellows Of Harvard College Methods for Making Particles Having Long Spin-Lattice Relaxation Times
EP2374016B1 (en) 2008-12-10 2017-05-10 University of York Pulse sequencing with hyperpolarisable nuclei
AU2010230330B2 (en) 2009-04-02 2015-06-25 Ge Healthcare Limited Use of a magnetic resonance imaging medium comprising hyperpolarized 13C pyruvate for the detection of inflammation or infection
CN102460136A (zh) * 2009-06-19 2012-05-16 皇家飞利浦电子股份有限公司 与利用具有轨道角动量的光子的超极化装置组合的mri温度测定
CA2772190A1 (en) * 2009-08-31 2011-03-03 Millikelvin Technologies Llc Systems and methods for producing hyperpolarized materials and mixtures thereof
EP2473199A1 (en) 2009-08-31 2012-07-11 Brain Watch Ltd. Isotopically labeled neurochemical agents and uses thereof for diagnosing conditions and disorders
US8968703B2 (en) 2009-09-10 2015-03-03 Ge Healthcare Limited 13C-MR detection using hyperpolarised 13C-fructose
US8427161B2 (en) * 2009-12-18 2013-04-23 General Electric Company Method and apparatus for generating hyperpolarized materials
EP2343568A1 (en) * 2009-12-30 2011-07-13 Koninklijke Philips Electronics N.V. Dynamic nuclear polarization apparatus with sample transport system
BR112012020235A2 (pt) * 2010-02-16 2017-11-07 Koninl Philips Electronics Nv "dispensador para a produção de um agente de contraste hiperpolarizado e sistema de exame de ressonância magnética"
JP5758982B2 (ja) 2010-04-08 2015-08-05 ブラッコ・イメージング・ソシエタ・ペル・アチオニＢｒａｃｃｏ Ｉｍａｇｉｎｇ Ｓ．Ｐ．Ａ． 過分極基質の製造方法およびｍｒｉのための方法
US8970217B1 (en) 2010-04-14 2015-03-03 Hypres, Inc. System and method for noise reduction in magnetic resonance imaging
JP5879333B2 (ja) 2010-05-03 2016-03-08 ジーイー・ヘルスケア・リミテッド Ｌｄｈ活性を決定するための過分極乳酸塩造影剤
DE102010017568B4 (de) 2010-06-24 2012-09-13 Johann Wolfgang Goethe-Universität Frankfurt am Main Hyperpolarisationseinrichtung und Verfahren zur Verabreichung eines hyperpolarisierten flüssigen Kontrastmittels
WO2012056447A1 (en) 2010-10-25 2012-05-03 Brain Watch Ltd. Isotopically labeled deoxy-glucose and derivatives thereof, compositions comprising them and uses thereof
US8786284B2 (en) * 2011-01-11 2014-07-22 Bridge12 Technologies, Inc. Integrated high-frequency generator system utilizing the magnetic field of the target application
US20140099262A1 (en) 2011-06-01 2014-04-10 Brain Watch Ltd. Isotopically labeled cdp-choline and uses thereof
WO2013053839A1 (en) 2011-10-12 2013-04-18 Bracco Imaging Spa Process for the preparation of hyperpolarized derivatives for use in mri analysis
US9693828B2 (en) 2011-12-05 2017-07-04 Bracco Imaging S.P.A. Composition comprising acetic anhydride and a gadolinium complex, and method for the use in hyperpolarisation in MRI analysis
GB2498181A (en) 2011-12-29 2013-07-10 Bruker Biospin Gmbh Device and method for rapid dynamic nuclear polarisation
IL223935A (en) 2012-01-13 2016-11-30 Gen Electric Fluid track system for decomposition and transport of hyper-polarized material
EP2624004A1 (en) * 2012-02-06 2013-08-07 Koninklijke Philips Electronics N.V. Temperature determination using magnetic resonance B1 field mapping
US8715621B2 (en) 2012-03-15 2014-05-06 Massachusetts Institute Of Technology Radical polarizing agents for dynamic nuclear polarization
EP2642310A1 (en) 2012-03-22 2013-09-25 Koninklijke Philips N.V. Interpolated three-dimensional thermal dose estimates using magnetic resonance imaging
WO2013149935A1 (en) 2012-04-02 2013-10-10 Bracco Imaging Spa Hyperpolarized amino acids
US9329245B2 (en) * 2012-04-11 2016-05-03 Bruker Biospin Ag MRI compatible method and device for rapid DNP on a solid state hyperpolarized sample material
WO2013167587A1 (en) 2012-05-07 2013-11-14 Albeda Innovation Aps Intra-operative cancer diagnosis based on a hyperpolarized marker
US8825132B2 (en) 2012-07-04 2014-09-02 Bruker Biospin Gmbh Field cycling method for magnetic resonance
US9381257B2 (en) 2012-07-13 2016-07-05 Bracco Imaging S.P.A. Triarylmethyl radicals
US9329246B2 (en) 2012-10-03 2016-05-03 Bruker Biospin Ag Method for hyperpolarization transfer in the liquid state
WO2014064194A1 (en) 2012-10-25 2014-05-01 Bracco Imaging Spa Hyperpolarized 2-oxoglutarate as metabolic agent in mr
US9404984B2 (en) 2012-11-06 2016-08-02 Bruker Uk Limited Method of hyperpolarization applying brute force using particulate acceleration agents
US20140200437A1 (en) * 2013-01-16 2014-07-17 Empire Technology Development Llc Detection of internal gas leakage
US10265421B2 (en) 2013-01-31 2019-04-23 Bracco Imaging S.P.A. Hyperpolarized esters as metabolic markers in MR
EP3016687B1 (en) * 2013-07-01 2017-08-09 Bracco Imaging S.p.A Hyperpolarized 1-13c-1,1-bis(acetoxy(methyl))-2,2'-cyclopropane as metabolic marker for mr
US9642924B2 (en) * 2013-08-29 2017-05-09 Duke University Contrast agents based on long-lived nuclear singlet states and related methods
US9874622B2 (en) 2013-09-27 2018-01-23 General Electric Company Hyperpolarized media transport vessel
EP2863229A1 (en) 2013-10-15 2015-04-22 Technische Universität München pH-biosensors based on compounds with pH-sensitive enolic groups for magnetic resonance imaging and spectroscopy and their uses
EP2891500B1 (en) 2014-01-07 2018-08-01 Cambridge Enterprise Limited Contrast agent for determination of aldehyde dehydrogenase (ALDH) activity
EP3015855A1 (en) 2014-10-27 2016-05-04 Klinikum rechts der Isar der Technischen Universität München Metal biosensors based on compounds with metal-sensitive chemical shifts for magnetic resonance spectroscopy and imaging
US10088536B2 (en) * 2015-03-27 2018-10-02 Bruker Biospin Corporation Sample introduction system and method for polarization
JP2018514795A (ja) * 2015-05-22 2018-06-07 ウニヴェルズィテート・ウルム 核スピンを超偏極させる方法
WO2017059092A1 (en) 2015-09-30 2017-04-06 Duke University Ascorbate formulations and methods of use as contrast agents
CN105738397B (zh) * 2016-02-04 2017-09-29 浙江大学 化合物中季碳纵向驰豫时间(t1)的分析方法
CN105866158B (zh) * 2016-03-31 2017-12-15 武汉大学 基于磁共振耦合的无损溶液浓度检测装置及检测方法
EP3258285B1 (en) 2016-06-14 2020-10-21 Bruker BioSpin GmbH Method for predicting chemical shift values of nmr spin systems in a sample of a fluid class, in particular in a sample of a biofluid
US10390727B2 (en) * 2017-04-21 2019-08-27 The Charles Stark Draper Laboratory, Inc. Apparatus and method for imaging currents using nanoparticles and low-field magnetic resonance imaging (MRI)
GB201710677D0 (en) * 2017-07-03 2017-08-16 Univ York Polorisation transfer via a second metal complex
EP3692013A4 (en) * 2017-09-12 2021-05-05 Memorial Sloan-Kettering Cancer Center HYPERPOLARIZED AND DEUTERIUM EXCHANGED HYPERPOLARIZED 13C AND 15C LABELED XANTHINE, ARGININE, GLUTAMINE AND UREA PROBES
US10520561B2 (en) 2017-09-27 2019-12-31 General Electric Company System and method for hyperpolarizing a substance and quenching radicals therein
US11771779B2 (en) * 2018-01-26 2023-10-03 Hadasit Medical Research Services & Development Limited Non-metallic magnetic resonance contrast agent
US10942237B2 (en) 2019-05-07 2021-03-09 GE Precision Healthcare LLC System and method for hyperpolarizing a substance
US11428763B2 (en) * 2020-02-28 2022-08-30 Government Of The United States Of America, As Represented By The Secretary Of Commerce Planar inverse anapole microresonator and performing inductive-detection electron paramagnetic resonance spectroscopy
WO2021198776A2 (en) * 2020-03-31 2021-10-07 Nvision Imaging Technologies Gmbh Systems and method for generation of hyperpolarized materials
CN112268918A (zh) * 2020-07-10 2021-01-26 中国科学院过程工程研究所 一种基于固体核磁共振波谱仪的材料吸附气体原位分析装置
WO2022045748A1 (ko) * 2020-08-25 2022-03-03 바이오그래핀 주식회사 탄소-13 함유 그래핀 양자점을 포함하는 mri 조영제 및 이의 제조 방법
CN114690099B (zh) * 2020-12-30 2025-05-06 中国科学技术大学 光超极化核磁共振成像装置及方法
WO2022269618A1 (en) * 2021-06-25 2022-12-29 Beacon Mri Ltd Particles for use in hyperpolarization
GB202111734D0 (en) 2021-08-16 2021-09-29 Cambridge Entpr Ltd Hyperpolarisation method and product
WO2024191654A1 (en) * 2023-03-10 2024-09-19 North Carolina State University Magnetic field control of sabre hyperpolarized molecules for processing and administration

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997037239A1 (en) * 1996-03-29 1997-10-09 Lawrence Berkeley National Laboratory Enhancement of nmr and mri in the presence of hyperpolarized noble gases
WO1998001766A1 (en) * 1996-07-05 1998-01-15 Nycomed Imaging As Method of electron spin resonance enhanced magnetic resonance imaging (esremri) with ex vivo dynamic nuclear polarisaton of an mr imaging agent
WO1998030918A1 (en) * 1997-01-08 1998-07-16 Nycomed Imaging As Method of magnetic resonance imaging

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2058714T3 (es) 1987-06-23 1994-11-01 Nycomed Innovation Ab Mejoras introducidas en formacion de imagenes por resonancia magnetica.
GB8817137D0 (en) 1988-07-19 1988-08-24 Nycomed As Compositions
GB8819753D0 (en) * 1988-08-19 1988-09-21 Nycomed As Apparatus
JPH02111747A (ja) * 1988-10-21 1990-04-24 Nippon Steel Chem Co Ltd 炭素１３標識５‐アミノレブリン酸及びその誘導体の製造方法
JP3166160B2 (ja) * 1989-02-15 2001-05-14 味の素株式会社 新規な▲上１▼▲上３▼ｃ標識アミノ酸及びその発酵的又は酵素的製造法
JP3175940B2 (ja) 1990-02-12 2001-06-11 ニコムド イノベーション アーベー トリアリールメチルラジカルおよび磁気共鳴造影法における不活性炭素フリーラジカルの用途
US5413917A (en) * 1990-07-18 1995-05-09 Board Of Regents, The University Of Texas System Method of determining sources of acetyl-CoA under nonsteady-state conditions
AU668691B2 (en) 1991-08-09 1996-05-16 Nycomed Innovation Ab Use of persistent free-radicals in magnetic resonance imaging
JPH0597711A (ja) * 1991-10-04 1993-04-20 節 ▲築▼山 生体組織代謝検査法
RU2063702C1 (ru) * 1992-07-20 1996-07-20 Леонид Аврамович Тютин Способ магнитно-резонансной томографии и устройство для его осуществления
US5464696A (en) * 1992-08-13 1995-11-07 Bracco International B.V. Particles for NMR imaging
GB9305351D0 (en) * 1993-03-16 1993-05-05 Nycomed Imaging As Improvements in or relating to contrast agents
US5545396A (en) 1994-04-08 1996-08-13 The Research Foundation Of State University Of New York Magnetic resonance imaging using hyperpolarized noble gases
US5479925A (en) 1994-06-23 1996-01-02 General Electric Company Magnetic resonance (MR) angiography in a low-field imaging magnet
GB9419203D0 (en) 1994-09-23 1994-11-09 Nycomed Innovation Ab Contrast media
US5617859A (en) 1995-10-02 1997-04-08 General Electric Company Apparatus and methods for magnetic resonance (MR) imaging of cavities using fluids polarized at low temperatures
JP3897841B2 (ja) * 1995-10-31 2007-03-28 独立行政法人科学技術振興機構 標識アシル−ｌ−カルニチンを用いた疾患診断剤
US6278893B1 (en) * 1998-01-05 2001-08-21 Nycomed Imaging As Method of magnetic resonance imaging of a sample with ex vivo polarization of an MR imaging agent
US6125654A (en) 1998-10-16 2000-10-03 Syracuse University Bulk production and usage of hyperpolarized 129 Xenon
FR2833953B1 (fr) 2001-12-21 2004-12-03 Sanofi Synthelabo DERIVES DE 3-HETEROARYL-3,5-DIHYDRO-4-OXO-4H-PYRIDAZINO [4,5-b]INDOLE-1-CARBOXAMIDE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997037239A1 (en) * 1996-03-29 1997-10-09 Lawrence Berkeley National Laboratory Enhancement of nmr and mri in the presence of hyperpolarized noble gases
WO1998001766A1 (en) * 1996-07-05 1998-01-15 Nycomed Imaging As Method of electron spin resonance enhanced magnetic resonance imaging (esremri) with ex vivo dynamic nuclear polarisaton of an mr imaging agent
WO1998030918A1 (en) * 1997-01-08 1998-07-16 Nycomed Imaging As Method of magnetic resonance imaging

Also Published As

Publication number Publication date
NO20003251D0 (no) 2000-06-22
BR9813244A (pt) 2000-10-10
JP2002501006A (ja) 2002-01-15
EP2119457A1 (en) 2009-11-18
NZ505151A (en) 2002-11-26
HUP0102093A3 (en) 2004-09-28
CA2317526C (en) 2008-09-16
AU752308C (en) 2003-05-15
IL136780A0 (en) 2001-06-14
JP4764548B2 (ja) 2011-09-07
BRPI9813244B1 (pt) 2016-12-13
CN100347562C (zh) 2007-11-07
WO1999035508A1 (en) 1999-07-15
HUP0102093A2 (hu) 2001-09-28
AU752308B2 (en) 2002-09-12
US6278893B1 (en) 2001-08-21
CN1527066A (zh) 2004-09-08
EP1046051A1 (en) 2000-10-25
NO334035B1 (no) 2013-11-25
ES2393833T3 (es) 2012-12-28
HU229718B1 (hu) 2014-05-28
NO20003251L (no) 2000-06-22
KR20010040318A (ko) 2001-05-15
EP2119457B1 (en) 2012-10-03
HK1069635A1 (zh) 2005-05-27
CN1285044A (zh) 2001-02-21
US6466814B1 (en) 2002-10-15
RU2221255C2 (ru) 2004-01-10
CN1138154C (zh) 2004-02-11
AU1775399A (en) 1999-07-26
CA2317526A1 (en) 1999-07-15

Similar Documents

Publication Publication Date Title
KR100699396B1 (ko) 자기 공명 연구 방법
US6453188B1 (en) Method of magnetic resonance imaging
US6311086B1 (en) Overhauser magnetic resonance imaging (ORMI) method comprising ex vivo polarization of a magnetic resonance (MR) imaging agent
US20020058869A1 (en) Methods of magnetic resonance imaging (MRI) using contract agent solutions formed from the dissolution of hyperpolarised materials
RU2271017C2 (ru) Способ исследования образца методом магнитного резонанса с применением магнитно-резонансного агента визуализации, поляризованного по ядерному спину (варианты)
IE63397B1 (en) Magnetic resonance imaging
Albert et al. Hyperpolarized and inert gas MRI: From technology to application in research and medicine
US7251519B2 (en) MR-method for the in vivo measurement of temperature or pH-value by means of a hyperpolarised contrast agent
JP2010536521A (ja) 方法及び該方法で使用するためのイメージング媒体
ES2274272T3 (es) Procedimiento para la produccion de 129xe hiperpolarizado.
WO2000072031A1 (en) Methods of magnetic resonance imaging (mri) using contract agent solutions formed from the dissolution of hyperpolarised materials
Suh et al. The Chemistry of Hyperpolarized Magnetic Resonance Probes
Chupp et al. Medical Imaging with Laser Polarized Noble Gases
JP2010532195A (ja) 磁気共鳴剤の過分極方法
HK1069635B (en) Method of magnetic resonance investigation

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

A201 Request for examination
AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

St.27 status event code: A-3-3-V10-V11-apl-PJ0201

AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PB0901 Examination by re-examination before a trial

St.27 status event code: A-6-3-E10-E12-rex-PB0901

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

B701 Decision to grant
PB0701 Decision of registration after re-examination before a trial

St.27 status event code: A-3-4-F10-F13-rex-PB0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

FPAY Annual fee payment

Payment date: 20130308

Year of fee payment: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

FPAY Annual fee payment

Payment date: 20140310

Year of fee payment: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

FPAY Annual fee payment

Payment date: 20150306

Year of fee payment: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

FPAY Annual fee payment

Payment date: 20160308

Year of fee payment: 10

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10

FPAY Annual fee payment

Payment date: 20170314

Year of fee payment: 11

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 11

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20180320

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20180320

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000